Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMA(III)) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes

Toxicology and Applied Pharmacology

Volumn 158, Issue 1, 1999, Pages 9-15

  Zakharyan, Robert A ^a   Ayala Fierro, Felix ^b   Cullen, William R ^c   Carter, Dean M ^b   Aposhian, H Vasken ^a,b  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC DERIVATIVE; ARSENOUS ACID DERIVATIVE; METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHEMICAL BINDING; CHEMICAL REACTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DETOXIFICATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER CELL; MALE; METHYLATION; NONHUMAN; RABBIT; REACTION ANALYSIS; URINARY EXCRETION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033168039     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8687     Document Type: Article

References (33)

1. Aposhian H. V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419.
2. Aposhian H. V., Aposhian M. Newer developments in arsenic toxicity. J. Am. Coll. Toxicol. 8:1989;1297-1305.
3. Aposhian H. V., Arroyo A., Cebrian M. E., Del Razo L. M., Hurlbut K. M., Dart R. C., Gonzalez-Ramirez D., Kreppel H., Speisky H., Smith A., Gonsebatt M. E., Ostrosky-Wegman P., Aposhian M. M. DMPS-arsenic challenge test: I. Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J. Pharmacol. Exp. Ther. 277:1997;938-944.
4. Bogdan G. M., Sampayo-Reyes A., Aposhian H. V. Arsenic binding proteins of mammalian systems. I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology. 93:1994;175-193.
5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Buchet J. P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: Relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129.
7. Buchet J. P., Lauwerys R. Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37:1988;3149-3153.
8. Burrows G. J., Turner E. E. A new type of compound containing arsenic. J. Chem. Soc. 117:1920;1373-1380.
9. Cebrian M. E., Albores A., Aguilar M., Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2:1983;121-133.
10. Challenger F. Biological methylation. Chem. Rev. 36:1945;315-361.
11. Chatterjee A., Das D., Mandal B. K., Chowdhury T. R., Samanta G., Chakraborty D. Arsenic in ground water in six districts of West Bengal, India: The biggest arsenic calamity in the world. Part I. Arsenic species in drinking water and urine of the affected people. Analyst. 120:1995;643-650.
12. Chen C. J., Chuang Y. C., Lin T. M., Wu H. Y. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 45:1985;5895-5899.
13. Cullen W. R., McBride B. C., Manji H., Pickett A. W., Reglinski J. The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 1:1989;71-78.
14. Cullen W. R., Reimer K. J. Arsenic speciation in the environment. Chem. Rev. 89:1989;713-764.
15. Review of Toxicology Study with Cacodylic Acid to Support Registration of Test Substance. 1992;USEPAOffice of Pesticides and Toxic Substance.
16. Fairchild E. J., Lewis R. J., Tathen R. L. Registry of Toxic Effects of Chemical Substances. 1977;National Institute for Occupational Safety and HealthU.S. Department of Health, Education and Welfare, Cincinnati.
17. Gailer, J, George, G. N, Pickering, I. J, Prince, R. C, Ringwald, S. C, Pemberton, J. E, Glass, R. S, Younis, H. S, DeYoung, D. W, and, Aposhian, H. V. 1999, The seleno-bis(S-glutathionyl) arsinium ion: A metabolic link between As(III) and Se(IV). Submitted for publication.
18. Georis B., Cardenas A., Buchet J. P., Lauwerys R. Inorganic arsenic methylation by rat tissue slices. Toxicology. 63:1990;73-84.
19. Guha Mazumder D. N., Chakraborty A. K., Ghose A., Gupta J. D., Chakraborty D. P., Dey S. B. Chronic arsenic toxicity from drinking water in rural West Bengal. Bull. WHO. 66:1988;499-506.
20. Healy S. M., Zakharyan R. A., Aposhian H. V. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat. Res. 386:1997;229-239.
21. Luo Z. D., Zhang Y. M., Ma L., Zhang Z. Y., He X., Wilson R., Byrd D. M., Griffiths J. G., Lai S., He L., Grumski K., Lamm S. H. Chronic arsenicism and cancer in Inner Mongolia - Consequences of well-water arsenic levels greater than 50 μg/l. Abernathy C. O., Calderon R. L., Chappell W. R. Arsenic: Exposure and Health Effects. 1997;55-68 Chapman & Hall, London.
22. Sancha A. M., Vega F., Venturino H., Fuentes S., Salazar A. M., Moreno V., Baron A. M., Rodriguez D. The arsenic health problem in northern Chile evaluation and control. A case study preliminary report. Proceedings of the International Seminar. Arsenic in the Environment and Its Incidence on Health. 1992;Universidad de Chile, Santiago. p. 187-202.
23. Science Scope, 1998, Science, 281, 1261.
24. Styblo M., Delnomdedieu M., Thomas D. J. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem.-Biol. Interact. 99:1996;147-164.
25. Styblo M., Yamauchi H., Thomas D. J. Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol. Appl. Pharmacol. 135:1995;172-178.
26. Surdu, S., Rudnai, P., Gurzau, A., Bodor, E., Dora, C., Gurzau, E. S., Fletcher, T., and Leonardi, G.1997. Natural arsenic in drinking water and adverse health effects in Romania. In Proceedings of the International Symposium on Environmental Epidemiology in Central and Eastern Europe: Critical Issues for Improving Health, pp. 43-46, International Society for Environmental Epidemiology, Smolence, Slovak Republic.
27. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8:1994;175-182.
28. Vahter M., Concha G., Nermell B., Nilsson R., Duluot F., Natajaran A. A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 293:1995;455-462.
29. Wildfang E., Zakharyan R. A., Aposhian H. V. Enzymatic methylation of arsenic compounds: VI. Arsenite and methylarsonic acid methyltransferase kinetics. Toxicol. Appl. Pharmacol. 152:1998;366-375.
30. World Health Organization, 1996, Guidelines for Drinking-Water Quality. Vol, 1, Recommendations., World Health Organization, Geneva, 1996.
31. 12 and glutathione does not require an enzyme. Toxicol. Appl. Pharmacol. 154:1999;287-291.
32. Zakharyan R. A., Wildfang E., Aposhian H. V. Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus, monkey are deficient in methyltransferases that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140:1996;77-84.
33. Zakharyan R. A., Wu Y., Bogdan G. M., Aposhian H. V. Enzymatic methylation of arsenic compounds. I: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8:1995;1029-1038.